# A Study to Evaluate the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection in Participants With Moderate-to-Severe Non-Cancer Chronic Pain

> **NCT07751094** · PHASE1 · NOT_YET_RECRUITING · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 27 (estimated)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** KL0011034 injection
- **DRUG:** Alfentanil Hydrochloride Injection

## Key facts

- **NCT ID:** NCT07751094
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-30
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2026-08-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07751094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07751094, "A Study to Evaluate the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection in Participants With Moderate-to-Severe Non-Cancer Chronic Pain". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07751094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*